NASDAQ:BPMX - BioPharmX Stock Price, News & Analysis

$0.33
0.00 (0.00 %)
(As of 08/18/2019 04:00 PM ET)
Today's Range
$0.32
Now: $0.3330
$0.34
50-Day Range
$0.31
MA: $0.45
$0.6369
52-Week Range
$0.30
Now: $0.3330
$6.75
Volume169,900 shs
Average Volume633,159 shs
Market Capitalization$3.49 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC). Its clinical-stage product candidates include BPX01, a topical antibiotic gel that has completed Phase II clinical trials for the treatment of inflammatory lesions of acne; BPX04, a topical antibiotic, which is in pre-Phase II feasibility study for the treatment of inflammatory lesions of rosacea; BPX02, a development stage product candidate for aesthetic dermatology applications; and BPX03, a molecular iodine tablet, which has completed pre-Phase III clinical trial for the treatment of periodic breast pain associated with FBC and cyclic mastalgia. The company serves pharmaceutical companies; physician's practices, including obstetricians and gynecologists, dermatologists, and general practitioners; and retail customers through retail sales channels and/or pharmacy outlets. It has collaboration and license agreement with Iogen LLC to develop molecular iodine formulations; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. The company is headquartered in Menlo Park, California.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BPMX
CUSIPN/A
CIKN/A
Phone650-889-5020

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$3.49 million
Next Earnings Date8/29/2019 (Estimated)
OptionableNot Optionable

Receive BPMX News and Ratings via Email

Sign-up to receive the latest news and ratings for BPMX and its competitors with MarketBeat's FREE daily newsletter.


BioPharmX (NASDAQ:BPMX) Frequently Asked Questions

What is BioPharmX's stock symbol?

BioPharmX trades on the NASDAQ under the ticker symbol "BPMX."

How were BioPharmX's earnings last quarter?

BioPharmX Corporation (NASDAQ:BPMX) posted its quarterly earnings data on Tuesday, June, 11th. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.13. View BioPharmX's Earnings History.

When is BioPharmX's next earnings date?

BioPharmX is scheduled to release their next quarterly earnings announcement on Thursday, August 29th 2019. View Earnings Estimates for BioPharmX.

What is the consensus analysts' recommendation for BioPharmX?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioPharmX in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BioPharmX.

Has BioPharmX been receiving favorable news coverage?

News headlines about BPMX stock have been trending negative this week, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BioPharmX earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for BioPharmX.

Who are some of BioPharmX's key competitors?

What other stocks do shareholders of BioPharmX own?

Who are BioPharmX's key executives?

BioPharmX's management team includes the folowing people:
  • Dr. Kin Foong Chan, Exec. VP of Research & Technology (Age 44)
  • Dr. David S. Tierney M.D., Pres, CEO, CFO and Director (Age 54)
  • Dr. José Zayas, Sr. VP of Operations
  • Ms. Joyce Goto, VP ,CAO & Controller (Age 45)
  • Dr. R. Kehl Sink, Sr. VP of Intellectual Property & Legal

How do I buy shares of BioPharmX?

Shares of BPMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioPharmX's stock price today?

One share of BPMX stock can currently be purchased for approximately $0.3330.

How big of a company is BioPharmX?

BioPharmX has a market capitalization of $3.49 million. View Additional Information About BioPharmX.

What is BioPharmX's official website?

The official website for BioPharmX is http://www.biopharmx.com/.

How can I contact BioPharmX?

The company can be reached via phone at 650-889-5020.


MarketBeat Community Rating for BioPharmX (NASDAQ BPMX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  64 (Vote Underperform)
Total Votes:  119
MarketBeat's community ratings are surveys of what our community members think about BioPharmX and other stocks. Vote "Outperform" if you believe BPMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BPMX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Featured Article: CD Ladder

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel